Preparation method of bimetallic nano-enzyme composite material with in-situ tumor microenvironment regulation and anti-tumor effects
A bimetallic nanotechnology, tumor microenvironment technology, applied in non-active ingredients medical preparations, medical preparations containing active ingredients, antitumor drugs, etc., can solve the problem of low tumor microenvironment response sensitivity and nanozyme catalytic efficiency It can improve the efficiency of tumor treatment, optimize the enzymatic reaction conditions, and achieve the effect of small nano-particle size.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0047] Specific Embodiment 1: In this embodiment, a method for preparing a bimetallic nanoenzyme composite material with in situ regulation of tumor microenvironment and anti-tumor effect is characterized in that the preparation method is specifically completed according to the following steps:
[0048] 1. Synthesis of bimetallic nanoparticles CoFe 2 o 4 :
[0049] ①. Add the cobalt source and the iron source to the solvent respectively, and stir evenly to obtain a mixed solution A;
[0050] ②. Put the mixed solution A in a three-necked round bottom flask, then vacuumize, and then raise the temperature of the mixed solution A to 90°C~120°C under the condition of magnetic stirring, and then magnetically stir and the temperature is 90°C~120°C. Reaction, obtain mixed solution B;
[0051] ③. Introduce nitrogen into the mixed solution B, then raise the temperature of the mixed solution B to 260°C-298°C, then react at 260°C-298°C, cool to room temperature, and obtain the reaction...
specific Embodiment approach 2
[0067] Specific embodiment two: the difference between this embodiment and specific embodiment one is: the cobalt source described in step one 1. is cobalt acetylacetonate; the iron source described in step one 1. is iron acetylacetonate; The solvent mentioned is dibenzyl ether, tetraethylene glycol or octadecene. Other steps are the same as in the first embodiment.
specific Embodiment approach 3
[0068] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is: the mass ratio of cobalt source and iron source described in step one 1. is 1: (0.5~2); The mass ratio of the total mass of the cobalt source and the iron source to the solvent is 1:(50-80). Other steps are the same as those in Embodiment 1 or 2.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Particle size | aaaaa | aaaaa |
| The average diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


